10X GENOMICS INC-CLASS A (TXG) Stock Analyst Earnings Estimates
NASDAQ:TXG - Nasdaq - US88025U1097 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 490.5M 64.16% | 516.4M 5.28% | 618.727M 19.82% | 610.63M -1.31% | 637.51M 4.40% | 695.4M 9.08% | 750.4M 7.91% | 799.82M 6.59% | 970.11M 21.29% | 1.059B 9.16% | 1.152B 8.78% | 1.246B 8.16% | |
| EBITDA YoY % growth | -31.18M 93.98% | -142.53M -357.12% | -159.437M -11.86% | -147.389M 7.56% | -124.92M 15.24% | -73.871M 40.87% | 87.264M 218.13% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -52.3M 90.16% | -167.9M -221.03% | -194.949M -16.11% | -188.585M 3.26% | -169.825M 9.95% | -123.706M 27.16% | -110.62M 10.58% | -140.188M -26.73% | -63.428M 54.76% | -20.604M 67.52% | 21.008M 201.96% | 59.186M 181.73% | |
| Operating Margin | -10.66% | -32.51% | -31.51% | -30.88% | -26.64% | -17.79% | -14.74% | -17.53% | -6.54% | -1.95% | 1.82% | 4.75% | |
| EPS YoY % growth | -0.52 89.86% | -1.47 -182.69% | -2.17 -47.62% | -1.43 34.10% | -1.29 10.10% | -0.92 28.63% | 0.20 122.02% | 0.51 150.00% | 0.80 58.00% | N/A | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.30 27.56% | -0.40 20.58% | -0.33 -2.15% | -0.27 10.72% | -0.23 21.18% | -0.38 4.12% | -0.30 8.02% | -0.23 12.77% | -0.15 34.85% |
| Revenue Q2Q % growth | 160.98M -12.50% | 142.43M 1.01% | 153.56M 0.30% | 162.29M 7.01% | 176.54M 9.67% | 155.11M 8.90% | 168.45M 9.70% | 177.52M 9.38% | 191.22M 8.32% |
| EBITDA Q2Q % growth | -31.527M -584.89% | -43.01M 14.33% | -31.32M -32.87% | -28.549M -98.86% | -22.657M 28.14% | -51.197M -19.04% | -38.168M -21.86% | -31.169M -9.18% | -27.411M -20.98% |
| EBIT Q2Q % growth | -40.951M -41.16% | -51.981M 12.49% | -42.559M -1.97% | -37.073M 10.64% | -32.361M 20.97% | -59.136M -13.76% | -45.965M -8.00% | -38.814M -4.70% | -35.007M -8.17% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.30 62.03% | -0.35 | 0.05 | 13.04% |
| Q2 2024 Q2Q % growth | -0.32 39.62% | -0.48 | 0.16 | 33.83% |
| Q1 2024 Q2Q % growth | -0.50 -13.64% | -0.51 | 0.01 | 1.07% |
| Q4 2023 Q2Q % growth | -0.41 -173.33% | -0.36 | -0.05 | -13.26% |
| Q3 2023 Q2Q % growth | -0.79 -113.51% | -0.46 | -0.33 | -70.21% |
| Q2 2023 Q2Q % growth | -0.53 7.02% | -0.41 | -0.12 | -30.01% |
| Q1 2023 Q2Q % growth | -0.44 -15.79% | -0.38 | -0.06 | -16.54% |
| Q4 2022 Q2Q % growth | -0.15 6.25% | -0.31 | 0.16 | 52.34% |
| Q3 2022 Q2Q % growth | -0.37 -146.67% | -0.47 | 0.10 | 21.05% |
| Q2 2022 Q2Q % growth | -0.57 -470.00% | -0.39 | -0.18 | -45.45% |
| Q1 2022 Q2Q % growth | -0.38 -245.45% | -0.32 | -0.06 | -20.32% |
| Q4 2021 Q2Q % growth | -0.16 95.87% | -0.09 | -0.07 | -83.39% |
| Q3 2021 Q2Q % growth | -0.15 76.92% | -0.20 | 0.05 | 26.60% |
| Q2 2021 Q2Q % growth | -0.10 75.61% | -0.26 | 0.16 | 61.95% |
| Q1 2021 Q2Q % growth | -0.11 45.00% | -0.28 | 0.17 | 60.14% |
| Q4 2020 Q2Q % growth | -3.87 -5,428.57% | -0.23 | -3.64 | -1,584.26% |
| Q3 2020 Q2Q % growth | -0.65 -96.97% | -0.31 | -0.34 | -110.91% |
| Q2 2020 Q2Q % growth | -0.41 | -0.56 | 0.15 | 26.55% |
| Q1 2020 Q2Q % growth | -0.20 | -0.13 | -0.07 | -49.34% |
| Q4 2019 Q2Q % growth | -0.07 | -0.11 | 0.04 | 38.80% |
| Q3 2019 Q2Q % growth | -0.33 | -0.12 | -0.21 | -172.28% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 151.654M -1.30% | 160.22M | -8.566M | -5.35% |
| Q2 2024 Q2Q % growth | 153.104M 4.28% | 151.59M | 1.514M | 1.00% |
| Q1 2024 Q2Q % growth | 141.006M 5.01% | 143.67M | -2.664M | -1.85% |
| Q4 2023 Q2Q % growth | 183.979M 17.78% | 184.63M | -651K | -0.35% |
| Q3 2023 Q2Q % growth | 153.644M 17.20% | 152.78M | 864K | 0.57% |
| Q2 2023 Q2Q % growth | 146.819M 28.11% | 141.36M | 5.459M | 3.86% |
| Q1 2023 Q2Q % growth | 134.285M 17.28% | 130.11M | 4.175M | 3.21% |
| Q4 2022 Q2Q % growth | 156.2M 8.85% | 149.65M | 6.55M | 4.38% |
| Q3 2022 Q2Q % growth | 131.1M 4.63% | 130.87M | 230K | 0.18% |
| Q2 2022 Q2Q % growth | 114.6M -1.04% | 118.37M | -3.77M | -3.18% |
| Q1 2022 Q2Q % growth | 114.5M 8.22% | 114.48M | 20K | 0.02% |
| Q4 2021 Q2Q % growth | 143.5M 27.90% | 150.02M | -6.52M | -4.35% |
| Q3 2021 Q2Q % growth | 125.3M 74.51% | 123.84M | 1.46M | 1.18% |
| Q2 2021 Q2Q % growth | 115.8M 169.93% | 113.98M | 1.82M | 1.60% |
| Q1 2021 Q2Q % growth | 105.8M 47.15% | 103.53M | 2.27M | 2.19% |
| Q4 2020 Q2Q % growth | 112.2M 49.00% | 101.41M | 10.79M | 10.64% |
| Q3 2020 Q2Q % growth | 71.8M 17.32% | 61.838M | 9.962M | 16.11% |
| Q2 2020 Q2Q % growth | 42.9M -23.12% | 29.856M | 13.044M | 43.69% |
| Q1 2020 Q2Q % growth | 71.9M 34.14% | 74.159M | -2.259M | -3.05% |
| Q4 2019 Q2Q % growth | 75.3M | 70.7M | 4.6M | 6.51% |
| Q3 2019 Q2Q % growth | 61.2M | 55.446M | 5.754M | 10.38% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1.87% | -1.87% | 0.66% | -0.54% |
| Revenue | 3.96% | 3.96% | 0.89% | 0.9% |